{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:13:04Z","timestamp":1649200384359},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00108-007-1990-y","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T14:56:00Z","timestamp":1200927360000},"page":"353-359","source":"Crossref","is-referenced-by-count":6,"title":["Antidementiva \u2013 wem n\u00fctzen sie wirklich?"],"prefix":"10.1007","volume":"49","author":[{"given":"H.","family":"F\u00f6rstl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"1990_CR1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/01.wnl.0000266625.31615.f6","volume":"69","author":"Auchus","year":"2007","unstructured":"Auchus AP, Brashear HR, Sallloway S et al. (2007) Galantamine treatment of vascular dementia. Neurology 69: 448\u2013458","journal-title":"Neurology"},{"key":"1990_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1368-5031.2006.00967.x","volume":"60","author":"Ballard","year":"2006","unstructured":"Ballard C, Lane R, Barone P et al. (2006) Cardiac safety of rivastigmine in Lewy body and Parkinson\u2019s disease dementias. Int J Clin Pract 60: 639\u2013645","journal-title":"Int J Clin Pract"},{"key":"1990_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-2006-951973","volume":"34","author":"Bickel","year":"2007","unstructured":"Bickel H, M\u00f6sch E, F\u00f6rstl H (2007) Kognitives Screening und Vorhersage von Demenzen mithilfe des SIDAM. Psychiatr Prax 34: 139\u2013144","journal-title":"Psychiatr Prax"},{"key":"1990_CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1212\/01.wnl.0000266627.96040.5a","volume":"69","author":"Black","year":"2007","unstructured":"Black SE, Doody E, Li H et al. (2007) Donepezil preserves cognition and global function in patients with severe Alzheimer\u2019s disease. Neurology 69: 459\u2013469","journal-title":"Neurology"},{"key":"1990_CR5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00023210-200620050-00005","volume":"20","author":"Bordier","year":"2006","unstructured":"Bordier P, Garrigue S, Lanusse S et al. (2006) Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer\u2019s disease. CNS Drugs 20: 411\u2013417","journal-title":"CNS Drugs"},{"key":"1990_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000104872","volume":"24","author":"Calabrese","year":"2007","unstructured":"Calabrese P, Essner U, F\u00f6rstl H (2007) Memantine in clinical practice. Dement Geriatr Cogn Disord 24: 111\u2013117","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1990_CR7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1176\/appi.ajp.161.3.532","volume":"161","author":"Cummings","year":"2004","unstructured":"Cummings JL, Schneider L, Tariot PN et al. (2004) Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer\u2019s disease. Am J Psychiatry 161: 532\u2013538","journal-title":"Am J Psychiatry"},{"key":"1990_CR8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/01.wnl.0000223333.42368.f1","volume":"67","author":"Cummings","year":"2006","unstructured":"Cummings JL, Schneider E, Tariot P et al. (2006) Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67: 57\u201363","journal-title":"Neurology"},{"key":"1990_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1368-5031.2005.00769.x","volume":"60","author":"Dantoine","year":"2006","unstructured":"Dantoine T, Auriacombe S, Sarazin M et al. (2006) Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer\u2019s disease who failed to benefit from previous cholinesterase inhibitor treatment. Int J Clin Pract 60: 110\u2013118","journal-title":"Int J Clin Pract"},{"key":"1990_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000107099","volume":"24","author":"Degermann-Gunnarsson","year":"2007","unstructured":"Degermann-Gunnarsson M, Kilander L, Basun H, Lannfelt L (2007) Reduction of phosphorylated Tau during memantine treatment of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 24: 247\u2013252","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1990_CR11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C et al. (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA-criteria. Lancet Neurol 6: 734\u2013746","journal-title":"Lancet Neurol"},{"key":"1990_CR12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1055\/s-2007-979399","volume":"132","author":"Egert","year":"2007","unstructured":"Egert S, Wagenpfeil S, F\u00f6rstl H (2007) Cholinesterase-Inhibitoren und Alzheimer Demenz: Metaanalyse zu Wirksamkeitsnachweis, Ursprung und Ergebnisverzerrung in publizierten Studien. Dtsch Med Wochenschr 132: 1207\u20131213","journal-title":"Dtsch Med Wochenschr"},{"key":"1990_CR13","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"Emre","year":"2004","unstructured":"Emre M, Aarsland D, Albanese A et al. (2004) Rivastigmine for dementia associated with Parkinson\u2019s disease. N Engl J Med 351: 2509\u20132518","journal-title":"N Engl J Med"},{"key":"1990_CR14","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","volume":"351","author":"Fahn","year":"2004","unstructured":"Fahn S, Oakes D, Shoulson I et al. (2004) Levodopa and the progression of Parkinson\u2019s disease. N Engl J Med 351: 2498\u20132508","journal-title":"N Engl J Med"},{"key":"1990_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","volume":"6","author":"Feldman","year":"2007","unstructured":"Feldman HH, Ferris S, Winblad B et al. (2007) Effect of rivastigmin on delay to diagnosis of Alzheimer\u2019s disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 6: 501\u2013512","journal-title":"Lancet Neurol"},{"key":"1990_CR16","doi-asserted-by":"crossref","unstructured":"F\u00f6rstl H (2008) Behandlungs- und Versorgungsstrategien bei Alzheimer und verwandten Demenzen. Nervenarzt (in Druck)","DOI":"10.1007\/s00115-008-2436-z"},{"key":"1990_CR17","doi-asserted-by":"crossref","unstructured":"F\u00f6rstl H, Bickel H, Fr\u00f6lich H et al. (2008) MCI-plus: leichte kognitive Beeintr\u00e4chtigung mit Vorzeichen rascher Verschlechterung. Dtsch Med Wochenschr (in Druck)","DOI":"10.1055\/s-2008-1046730"},{"key":"1990_CR18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1192\/bjp.163.3.364","volume":"163","author":"F\u00f6rstl","year":"1993","unstructured":"F\u00f6rstl H, Burns A, Levy R et al. (1993) Neuropathological correlates of behavioural disturbance in confirmed Alzheimer\u2019s disease. Br J Psychiatry 163: 364\u2013368","journal-title":"Br J Psychiatry"},{"key":"1990_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/pds.1345","volume":"16","author":"Frankfort","year":"2007","unstructured":"Frankfort SV, Appels BA, Boer A de et al. (2007) Identification of responders and reactive domains to rivastigmine in Alzheimer\u2019s disease. Pharmacoepidemiol Drug Saf 16: 545\u2013551","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1990_CR20","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa066583","volume":"357","author":"Howard","year":"2007","unstructured":"Howard RJ, Juszczak E, Ballard C et al. (2007) Donepezil for the treatment of agitation in Alzheimer\u2019s disease. N Engl J Med 357: 1382\u20131392","journal-title":"N Engl J Med"},{"key":"1990_CR21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(07)70195-3","volume":"6","author":"Kavirajan","year":"2007","unstructured":"Kavirajan H, Schneider LS (2007) Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 6: 782\u2013792","journal-title":"Lancet Neurol"},{"key":"1990_CR22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jnnp.2006.096420","volume":"78","author":"Monastero","year":"2007","unstructured":"Monastero R, Camarda C, Pipia C, Camarda R (2007) Visual hallucinations in Alzheimer\u2019s disease due to memantine: report of three cases. J Neurol Neurosurg Psychiatry 78: 546","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1990_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/WAD.0b013e318032cf29","volume":"21","author":"Pomara","year":"2007","unstructured":"Pomara N, Ott BR, Peskind E, Resnick EM (2007) Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial. Alzheimer Dis Assoc Disord 21: 60\u201364","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1990_CR24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp.2004.050682","volume":"76","author":"Ravina","year":"2005","unstructured":"Ravina B, Putt M, Siderowf A et al. (2005) Donepezil for dementia in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled, crossover study. J Neurol Neurosurg Psychiatry 76: 934\u2013939","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1990_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000102569","volume":"24","author":"Saumier","year":"2007","unstructured":"Saumier D, Murtha S, Bergman H et al. (2007) Cognitive predictors of donepezil therapy response in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 24: 28\u201335","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1990_CR26","doi-asserted-by":"crossref","unstructured":"Schwalen S, F\u00f6rstl H (2008) Sechs Fragen zur Alzheimer Demenz: Wissen und Einstellung in einer repr\u00e4sentativen Bev\u00f6lkerungsstichprobe. Neuropsychiatrie (in Druck)","DOI":"10.5414\/NEPBand22035"},{"key":"1990_CR27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00115-004-1856-7","volume":"76","author":"Singer","year":"2005","unstructured":"Singer M, Romero B, Koenig E et al. (2005) Albtr\u00e4ume bei Patienten mit Alzheimer-Demenz durch Donepezil \u2013 therapeutischer Effekt ist abh\u00e4ngig vom Einnahmezeitpunkt. Nervenarzt 76: 1127\u20131129","journal-title":"Nervenarzt"},{"key":"1990_CR28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/emj.2006.036251","volume":"23","author":"Suleyman","year":"2006","unstructured":"Suleyman T, Tevfik P, Abdulkadir G, Ozlem S (2006) Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J 23: 641\u2013642","journal-title":"Emerg Med J"},{"key":"1990_CR29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT et al. (2004) Memantine treatment in patients with moderate to severe Alzheimer\u2019s disease already receiving donepezil: a randomized controlled trial. JAMA 291: 317\u2013324","journal-title":"JAMA"},{"key":"1990_CR30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/gps.1788","volume":"22","author":"Winblad","year":"2007","unstructured":"Winblad B, Cummings J, Andreasen N et al. (2007) A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer\u2019s disease \u2013 rivastigmine patch versus capsule. Int J Geriatr Psychiatry 22: 456\u2013467","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1990-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1990-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1990-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:07Z","timestamp":1558584727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1990-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["1990"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1990-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}